YM-53601 (Standard)

Overview

YM-53601 (Standard) is the analytical standard of YM-53601 ( HY-100313A ). This product is intended for research and analytical applications. YM-53601 , a squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in vivo. YM-53601 inhibits squalene synthase derived from human hepatoma cells with an IC50 of 79 nM. Lipid-lowering agent. YM-53601 is also an inhibitor of farnesyl-diphosphate farnesyltransferase 1 (FDFT1) enzyme activity and abrogates HCV propagation.

Application

Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Metabolic Disease | Products > Research Areas > Infection | Products > Signaling Pathways > Farnesyl Transferase | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > HCV

Product Information

• Catalog No.: HY-100313AR
• CAS No.: 182959-33-7
• Molecular Formula: C21H22ClFN2O
• Molecular Weight: 372.86
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source